Download PDFPDF

Biomarkers for the diagnosis of Alzheimer’s disease, dementia Lewy body, frontotemporal dementia and vascular dementia
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Is it really worth it?

    Currently there is no cure for dementia. Dementia as we know is largely a clinical diagnosis. Unless of course we are looking at more rarer dementia differential for example CJD, autoimmune encephalopathy etc, putting elderly patients through further testing for CSF when clinically diagnosis seems probable, is not going to change future management plan and it is often distressing for patients and their carers. Although this is not by any way to challenge the utility of biomarker testing, but where we stand now is that dementia is progressive Neuro degenerative condition and what family and carer expectations are that of more person centres and holistic approach in providing that care and support.

    Conflict of Interest:
    None declared.